Cure My Disease

Don't miss your cure!

 Log in / Sign up

8,320 adults tracked for years to uncover hidden disease risks

NCT ID NCT03197363

NEW Knowledge-focused Sponsor: Medical University of Bialystok Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 16, 2026 · Last updated Oct 16, 2026

Summary

Researchers in Bialystok, Poland, are following 8,320 randomly selected residents aged 20 to 80 to understand how common diseases develop. Participants undergo imaging, physical tests, and detailed questionnaires about lifestyle and health. The goal is to find new risk factors for heart disease, diabetes, obesity, lung disease, neurodegenerative disease, and cancer. By linking this data with stored biological samples, the study aims to improve prevention, diagnosis, and treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If researchers identify new risk factors, this could improve prevention, diagnosis, and treatment for heart disease, diabetes, and other common conditions.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Findings may not apply to people outside Bialystok, and the long follow-up means results take years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 8,320 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2018

Expected to finish

Jun 2034

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Inhabitants of Bialystok (selected from the registry of Bialystok inhabitants). Stratified sampling will be performed, based on sex and age strata (10-year intervals) in order the sample to be representative for gender and age distribution in Bialystok population.

Ages

20 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * inhabitants of Bialystok (randomly selected from the registry of Bialystok inhabitants) * age 20-80 Exclusion Criteria: * disagreement of the invited person

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder diabetes mellitus lung disorder neoplasm neoplastic disease or syndrome neurodegenerative disease Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular diseases Diabetes Neoplastic disease Neuro-degenerative disease Obesity Pulmonary disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Population Research Center, Medical University of Bialystok

    Bialystok, 15-274, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.